By Angela Mers Regional Marketing and PR Manager at YPO Honoring Global Innovators Initiating Breakthroughs that Inspire Positive Transformation DALLAS – 17 May 2017 – YPO, the premier chief executive leadership organization in the world, concluded its second-annual YPO Innovation Week by announcing the winners of the Global Innovation Awards, which honors those YPO members who have created transformative innovations and nurture continued growth and opportunity for leaders around the world. In addition to recognizing the top ten innovators from among more than 24,000 YPO members across 130 countries, the Global Innovation Awards also honors Asia’s top innovator and the top young adult innovator, who is a child of YPO member (ages 17-29). “The Global Innovation Awards highlight those distinguished innovators who are leading the way in creating forward-thinking companies and significant opportunities for this and the next generation. These leaders are making an indelible mark in the world,” said Keith Alper, Chair of YPO Innovation Week. During May, 2017 YPO Innovation Week connected influential entrepreneurs, innovators and thought leaders to exchange ideas about inspiration, breakthroughs and transformation through more than 50 signature events, live two-way interactive video casts and livestream events around the world. At the conclusion of the week, YPO announced the top Asian innovator in Hong Kong and the Global Innovation Award winner in New York City. 2017 Global Innovation Award Winners: Global Innovation Award – Michael Golway, President and CEO of Advanced Solutions, Inc Michael Golway is the inventor of the BioAssemblyBot®, the world’s first 3D human tissue printer that uses a six-axis robot (www.bioassemblybot.com). BioAssemblyBot® is a disruptive technology that allows researchers to complete their experiments faster, pharmaceutical companies to take cost and time out of the drug development process and a new approach to solve for diseased or failing organs. In addition to selling the innovation to customers around the world, Advanced Solutions Life Sciences is using the BioAssemblyBot® technology platform in its own labs to help advance the science including developments to support the goal of 3D printing human organs. Global Innovation Award – Asia Top Innovator – Tadahiro Kawada, President of Kawada Industries Tadahiro Kawada is the President of Kawada Technologies, Inc, overseeing multiple businesses including construction, ICT, aviation, environmental, and robotics. With a background in mechanical and aerospace engineering, he led the research and development of humanoid robots at Kawada, collaborating with the University of Tokyo and Japanese government agencies. Since 2000, the Kawada Group has developed more than 10 variations of biped humanoid robots. Kawada’s newest robotics product, NEXTAGE, is an industrial-use collaborative robot (cobot) that empowers manufacturing companies, facilitating factory innovation and labor efficiencies. Global Innovation Award – YPO Next Generation – Nicholas Ackerman Nicholas Ackerman is the developer of bCODE technology, providing companies with a method of delivering tickets to all mobile users by utilizing SMS. bCODE technology has since evolved, now offering services for retailers and credit card companies, allowing for consistent consumer engagement and dynamic delivery of incentives to reward or encourage loyalty behavior. “Congratulations to the 2017 Global Innovation Award honorees as they highlight the innovation and breadth of talent of the global YPO network,” said Scott Mordell, CEO of YPO. “Acknowledging their originality and inventiveness is a perfect way to cap off the second-annual YPO Innovation Week.” Finalists: The top finalists for the YPO Global Innovation Awards include: Rex Briggs, CEO of Marketing Evolution Marketing Evolution is an independent SaaS platform for measuring and optimizing the entire marketing mix and creator of ROI BrainTM, which uses person-level analysis to deliver detailed message rotation, targeting and media mix optimization for every media. Mark Hadland, CEO of Level11 Level 11, a user experience software development firm, has recently partnered with Carnival Cruise Corp. to develop the largest guest-facing, Iot platform designed to deliver personalized guest experiences at scale. Gregg Hill of Frustum Frustum is a pioneer in functional generative design and topology optimization software for industrial designers and engineers, recently introducing its proprietary geometry kernel designed to move the 3D Computer-Aided Design market to true generative design and optimization. Samir Kulkarni, CEO of Showcase Showcase is a 105-store national chain based in Canada and one of the most innovative retailers in North America, fueled by groundbreaking trend technology and a nimble supply chain. George Kurtz, President, CEO and Co-Founder of CrowdStrike CrowdStrike is a leading cybersecurity company focusing on next-generation endpoint protection, threat intelligence and incident response through cloud-based endpoint protection. Stuart Lacey, Founder and CEO of Trunomi Trunomi is reinventing the way in which financial institutions interact with customer data, securely connecting financial institutions to their customers with a consent-based data sharing platform. Its consent-based platform revolutionizes the way financial institutions interact with customer data, in full compliance with data privacy regulations. Rao Mulpuri, CEO of View, Inc View, Inc is the first company to successfully advance the large-scale commercialization of dynamic glass, a new generation of architectural glass that transitions through multiple tint states to control the sun’s energy. Josh Siegel, Chairman and CEO of StoneCastle Financial Corp. Siegel has created Cambr, a financial toolkit that enables brands and developers to easily build financial apps and features on StoneCastle’s network of more than 700 insured community banks, essentially the first Banking in the Cloud (BAAS) platform. Tej Tadi, Founder and CEO of MindMaze Tadi founded MindMaze in 2011 to develop technologies that help patients recover from brain injuries. The company recently has launched devices, which use virtual reality, brain imaging and gaming technologies to retrain the brain in stroke victims. MindMaze is now developing solutions for spinal cord injury and amputee patients. About YPO Innovation Week YPO Innovation Week offers global chief executives with learning events and networking opportunities designed to infuse innovation into their companies, form strategic partnerships, and positively affect their businesses and the communities in which they work. YPO leaders were able to leverage new partnerships in innovation, integrate innovation into their company culture, and convert ideas into actionable plans, through YPO Innovation Week. YPO Innovation Week 2017 held events in more than 30 countries around the world, including Tel Aviv, Israel; New York, New York; Melbourne, Australia, Silicon Valley, California; Hong Kong, China and more, all dedicated to driving innovation across a diverse range of industries. The week featured idea jams, workshops, live-streamed panels, insider company tours, global conference calls, TED-style presentations and debates. About YPO The premier leadership organization of chief executives in the world. YPO is the global platform for chief executives to engage, learn and grow. YPO members harness the knowledge, influence and trust of the world’s most influential and innovative business leaders to inspire business, personal, family and community impact. Today, YPO empowers more than 24,000 members in more than 130 countries, diversified among industries and types of businesses. Altogether, YPO member-run companies employ more than 15 million people and generate USD6 trillion in annual revenues. Leadership. Learning. Lifelong. For more information, visit ‪ypo.org Contact: press@ypo.org Original Source: https://legacy.ypo.org/2017/05/ypo-announces-2017-global-innovation-award-winners/

Advanced Solutions Life Sciences has created a six-axis robotic 3D printing workstation that can be used to create tissue, cells, biological gels and coatings, and perhaps eventually an entire human organ, such as a heart. The six-axis robot is more precise than the typical three-axis bioassembly tool used to print tissue, which Lehanna Sanders, the company’s business development manager, says are slow and don’t typically handle curves well. Currently, researchers use her company’s Bioassembly Bot to fabricate biological tissue structures on which to run experiments, but in the future it could help with patient diagnostics and may be used to print living tissue inside patients during surgery, she says. The printer, for example, isn’t restricted to printing on a flat surface. A video at the company’s web site shows an angiogram printed on to the contoured surface of the heart, for example. “This comes in at an angle to make structures on something that’s not a flat surface, which is important for eventually generating tissues and—down the line—full organs,” Sanders says. The Louisville, KY-based company came up with the design for the multi-axis printer and incorporated the modular heads on an Epson robotic arm. The arm and the number of axes allow “surgeon-like” precision when building 3D tissue structures, says Michael Golway, the company’s president and chief executive officer. It’s the robotic nature of the tool, along with its six axes, that turn the 3D printer into a 3D biofabrication device. Up to ten independent types of materials can be loaded in the printing workstation during one print run. That means experimenters can use different cell types or materials within a single test, Sanders says. The machine can be loaded with up to ten different types of fluids for printing and is capable of printing organ structures down to a resolution of 20 µm in a 300 mm by 250 mm by 150 mm build volume. The workstation includes automated syringe exchange, automatic calibration of syringe tips, and a variety of utilities aimed at precisely leveling the print bed. The device also includes a live feed of the action as it happens. Relying on its laser sensors, the robot arm can, for example, select a syringe from a storage rack and dispense organic materials in set amounts to build, from scratch, a functioning biological model. For another type of experiment, the pick-and-place robotic nature of the arm allows tool to pick up a multi-well plate to begin an experiment. “Within the wells, you can print 3D tissue structures, like a tissue scaffold, at a pretty small scale, and then you can print cells within that and do different co-culture experiments,” she adds. “So you can generate a working unit of an organ within each well and it’d be in 3D but at a very small scale.” Or, researchers might print a single form of a 3D tissue structure to run analysis of different chemical structures within the wells, Sanders says. The 3D printing robot automates such experiments. “We print the tissues, perform the experiment, and a lid can be added to the plate. The entire experiment is done without anyone touching it,” she says. Also important is the Tissue Structure Information Modeling (TSIM) software Advanced Solutions developed along with the hardware. That software acts as a CAD program for biology and calling upon graphical images rather than lines of manual codes. With TSIM, researchers can scan organs and tissues, then use those scans to create and manipulate 3D models that the BioAssembly Bot prints for experiments, Sanders says. Those models—along with 3D prints of those models—will one day be helpful in diagnosing patients, she says. Because TSIM is integrated with the robotic assembly device, physicians and researchers can import patient-specific data sets from computer tomography scans or magnetic resonance images and generate 3D structures based on that data. “There’s already a lot of work being done in 3D printing people’s tissues based on CT or MRI as a diagnostic tool and we fit well into that,” she says. Alternatively, researchers can build their own model and assign various material properties to parts of the model, specify print parameters, and eventually hold in their hands a 3D version of the printed model. The robotic device can also print from the stereolithography files other CAD systems generate for 3D printing, Sanders says. Due to its flexibility—again, including its capability to print on contoured surfaced like the heart—the biological robotic assembly machine could one day operate within a patient, Sanders said. “If something needed to be printed in situ, that’s possible I think. “Our long-reaching goal for this to directly affect patients,” she adds. Jean Thilmany is an independent writer. Original Source: https://www.asme.org/engineering-topics/articles/bioengineering/a-robot-that-prints-tissue

Read the full article here: https://blog.a2ktechnologies.com.au/autodesk-university-2014-exhibition-hall-highlights/

LOUISVILLE, Ky. – April 1, 2014: Michael Golway, President and CEO of Advanced Solutions Inc., a diversified technology company, will be joining a panel of innovation experts and community leaders, as part of the Young Professional Association of Louisville’s (YPAL) Innovate Louisville Series. Over the past year, YPAL has explored the importance of technology-based companies to the Ohio Valley Region and Louisville, Kentucky, to be more specific. This has led them to take the YPAL “Develop Louisville” series and transform it into, what has become, “Innovate Louisville”. With the help of team members from YPAL, International Institute of Business Analysis (IIBA) and Technology Association of Louisville Kentucky (TALK), Innovate Louisville kicks off with an amazing evening of discussing the question, “How do we use innovations in data and technology to improve quality of life?” They’ve worked together to explore this question, as well as enlist the guidance of Louisville’s most prominent leaders in innovation. The evening will explore the future of technology and innovation in Kentucky, the economic and social impacts on the Louisville community, along with the personal stories of each of the four community leaders, listed below: Greg Fischer, Mayor of Louisville Theresa Reno-Weber, Chief of Performance Improvement for Louisville Metro Government Karen Siers-Hartlage, Principal Project Manager/ Scrum Master/ Agile Coach for Churchill Downs Michael W. Golway P.E., President and CEO of Advanced Solutions Moderator, Chad Keinenan, Enterprise Business Consultant and Louisville IIBA Chapter Member, will lead the discussion at 6:00p.m. on the evening of April 3rd in the Nucleus Innovation Park, 300 E. Market St, Louisville, KY, 40202.

They call it Tissue Structure Information Modeling (TSIM), and it’s “an intuitive software tool that empowers doctors and scientists to design, visualize, collaborate, simulate and analyze 3D computer models of complex tissue structures.” It’s yet another entrant in a race to replicate the critical structures within the human body with 3D printing. The conceit that scientists will one day be able to bio-print tissues and organs is fast becoming more than a wild scheme, and at the heart of the problem lies the difficulty of printing artificial vascular networks capable of functioning in conjunction with the wild complexity of the human body’s circulatory system. In Kentucky, Advanced Solutions has created what they say is the next generation in 3D printing, the BioAssemblyBot. It’s essentially a multi-axis robot which can replicate 3D tissue assemblies of organic design. Using the company’s TSIM Software, doctors and researchers can construct biological models for later fabrication with the BioAssemblyBot. Employing laser sensors, a robot arm is used to select a syringe from a storage rack and dispenses organic material of a particular set of characteristics to build, from scratch, a functioning biological model. Advanced Solutions Life Sciences works on the “discovery, design, development and commercialization of integrated software and hardware solutions for the fields of science that involve living organisms, molecular biology, and biotechnology.” That’s a mighty big target, but the company sees applications for their technology solutions in the fields of health, agriculture, medicine, medical device manufacturing, the pharmaceutical industry and the food science industry, so the potential rewards are tantalizing indeed. While the actual use of the device for human, patient-ready biological structures might well be three to five years away, the work being done now in preparation for that day is more than startling, it’s a harbinger of a future certain to materialize. “With TSIM, my team can minimize empirical efforts writing scripts and troubleshooting print-runs,” says James Hoying, PhD for the Cardiovascular Innovation Institute. “I can create the desired cellular structure, manipulate, instruct the printer what material to be printed and the integrated system handles the rest, fabricating in real space the object I created in 3D computer space. This is a wonderful, enabling platform for my work.” Once the TSIM software has assembled a precise 3D model of the tissue structure required, cell layers, cell types, their locations, and their attributes are then built by the BioAssemblyBot. The technology won’t be cheap – the price of the machine starts at $159,995 – but when you consider that this patent-pending device uses a six-axis robot arm and can be loaded with up to ten independent delivery systems, the price seems reasonable. Capable of printing organ structures down to a resolution of 20µm in a 300mm x 250mm x 150mm build volume, the BioAssemblyBot also features automated syringe exchange, automatic calibration of syringe tips, and a variety of utilities aimed at precisely leveling the print bed. The device also includes a live feed of the action as it happens. Original Source:https://www.3dprinterworld.com/article/building-human-replacement-parts-bioassemblybot